Calament G, Cauvin J M, Robaskiewicz M, Nousbaum J B, Lepage M, Robert F X, Gourlaouen A, Gouérou H
Service de Gastroentérologie, CHU Morvan, Brest.
Gastroenterol Clin Biol. 1993;17(1):9-16.
The incidence of esophageal cancer in the French county of Finistère is among the highest in France (26.7/10(5) for males). The authors analyzed the survival rates for squamous cell carcinomas from data of the Finistère tumor registry in order to describe different prognostic groups of patients using the multivariate Cox model. From 1984 to 1988, 716 patients with esophageal squamous cell carcinomas were registered in an overall population of 828,000 residents: 675 males and 41 females. Survival was calculated using the actuarial method. Six hundred and seventy five patients died before the point date (31 Dec 1989). Only one patient was lost to follow-up. The actuarial survival rates of all patients were 89 +/- 1% at 3 months, 68 +/- 2% at 6 months, 37 +/- 2% at one year, 12 +/- 1% at 3 years and 6 +/- 1% at 5 years; median survival was 9.1 +/- 0.4 months. Survival was significantly related to cancer size, tumor extension and surgical contraindications. In the Cox model, age, cancer size, surgical contraindications, year of diagnosis were independent prognostic predictors. There was a significant increase in survival rates after 1986: median survival was 8.1 +/- 0.4 months between 1984 and 1986 and 10.1 +/- 0.5 months between 1987 and 1988. Patients treated by curative resection had higher actuarial survival rates (median survival 22.5 +/- 4.1 months) than patients who underwent palliative resection (median survival 11.3 +/- 1.2 months). In patients with cancer managed surgically, the prognostic predictors were tumor size, curative vs palliative surgical resection and association with chemotherapy.(ABSTRACT TRUNCATED AT 250 WORDS)
法国菲尼斯泰尔省的食管癌发病率在法国位居前列(男性发病率为26.7/10⁵)。作者分析了菲尼斯泰尔肿瘤登记处的数据中鳞状细胞癌的生存率,以便使用多变量Cox模型描述不同的患者预后组。1984年至1988年期间,在82.8万居民的总人口中登记了716例食管鳞状细胞癌患者:675例男性和41例女性。采用精算方法计算生存率。675例患者在截止日期(1989年12月31日)前死亡。仅1例患者失访。所有患者的精算生存率在3个月时为89±1%,6个月时为68±2%,1年时为37±2%,3年时为12±1%,5年时为6±1%;中位生存期为9.1±0.4个月。生存率与肿瘤大小、肿瘤扩展和手术禁忌证显著相关。在Cox模型中,年龄、肿瘤大小、手术禁忌证、诊断年份是独立的预后预测因素。1986年后生存率显著提高:1984年至1986年期间中位生存期为8.1±0.4个月,1987年至1988年期间为10.1±0.5个月。接受根治性切除的患者精算生存率(中位生存期22.5±4.1个月)高于接受姑息性切除的患者(中位生存期11.3±1.2个月)。在接受手术治疗的癌症患者中,预后预测因素为肿瘤大小、根治性与姑息性手术切除以及是否联合化疗。(摘要截取自250字)